These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 12509916)

  • 21. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abnormalities of microsatellite in transitional cell carcinoma of urinary bladder related with aromatic amine exposure].
    Di XB; Zheng S; Chen W; Li JL; Liu JZ; Zhang P; Li AQ; An ZY; Feng PW; Gao YN
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Oct; 23(5):359-61. PubMed ID: 16266515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
    J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction.
    Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Steineck G
    BJU Int; 2001 Jun; 87(9):876-81. PubMed ID: 11412230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs].
    Shuin T; Kamata M; Ashida S
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1719-25. PubMed ID: 12402420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
    Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
    Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
    Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.
    Natrajan R; Louhelainen J; Williams S; Laye J; Knowles MA
    Cancer Res; 2003 Nov; 63(22):7657-62. PubMed ID: 14633686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
    J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
    Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
    Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
    Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
    Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder.
    Saetta AA; Goudopoulou A; Korkolopoulou P; Voutsinas G; Thomas-Tsagli E; Michalopoulos NV; Patsouris E
    Eur J Surg Oncol; 2004 Sep; 30(7):796-803. PubMed ID: 15296997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
    Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
    Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients.
    Ismail HM; Medhat AM; Karim AM; Zakhary NI
    Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.